Literature DB >> 15698421

Role of macromolecular IgA in IgA nephropathy.

Paul J M van der Boog1, Cees van Kooten, Johan W de Fijter, Mohamed R Daha.   

Abstract

Primary IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis, leading to progressive renal failure in almost one third of the patients. The disease is characterized by mesangial deposits of IgA. The pathogenesis of IgAN remains incompletely understood. The basic abnormality of this disorder lies within the IgA immune system rather than in the kidney. Elevated levels of IgA and IgA-containing complexes are found in sera of most patients with IgAN, but increased levels alone are not sufficient to develop IgAN. Therefore abnormal physicochemical properties of circulating IgA, such as size, charge, and glycosylation may play a role. This is supported by the presence of altered glycosylation of serum and mesangial IgA in patients with IgAN. Although the precise origin and nature of the mesangial IgA deposits are still uncertain, they contain at least in part macromolecular IgA, which may be derived from circulating IgA-containing complexes. Recently, novel insights have been obtained in the molecular composition of circulating high-molecular-weight IgA, which might include complexes with underglycosylated IgA1 and IgA-CD89 complexes. In this review various aspects of macromolecular IgA in relation to IgAN will be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15698421     DOI: 10.1111/j.1523-1755.2005.00146.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.

Authors:  Azusa Hashimoto; Yusuke Suzuki; Hitoshi Suzuki; Isao Ohsawa; Rhubell Brown; Stacy Hall; Yuichi Tanaka; Jan Novak; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  Am J Pathol       Date:  2012-08-05       Impact factor: 4.307

3.  Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium.

Authors:  Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2019-06-21       Impact factor: 10.121

4.  Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.

Authors:  Małgorzata Mizerska-Wasiak; Jadwiga Małdyk; Agnieszka Rybi-Szumińska; Anna Wasilewska; Monika Miklaszewska; Jacek Pietrzyk; Agnieszka Firszt-Adamczyk; Roman Stankiewicz; Beata Bieniaś; Małgorzata Zajączkowska; Katarzyna Gadomska-Prokop; Ryszard Grenda; Agnieszka Pukajło-Marczyk; Danuta Zwolińska; Maria Szczepańska; Agnieszka Turczyn; Maria Roszkowska-Blaim
Journal:  Pediatr Nephrol       Date:  2014-12-31       Impact factor: 3.714

5.  Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.

Authors:  Qin Dai; Jian Liu; Yun-lei Du; Xu Hao; Ji Ying; Yun Tan; Li-qun He; Wei-ming Wang; Nan Chen
Journal:  Acta Pharmacol Sin       Date:  2016-01-18       Impact factor: 6.150

Review 6.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

7.  Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.

Authors:  Y Yan; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

8.  Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response.

Authors:  J W Eijgenraam; B D Oortwijn; S W A Kamerling; J W de Fijter; A W L van den Wall Bake; M R Daha; C van Kooten
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

9.  Qufeng Tongluo Prescription () inhibits mesangial cell proliferation and promotes apoptosis through regulating cell cycle progression.

Authors:  Xi-li Wu; Peng An; Bing-yu Ye; Xing-min Shi; Wan-sen Sun; Rong-guo Fu; Zhu Wang; Cheng-lin Qiao
Journal:  Chin J Integr Med       Date:  2013-12-05       Impact factor: 1.978

10.  Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.

Authors:  Xinfang Xie; Pan Liu; Li Gao; Xue Zhang; Ping Lan; Vanesa Bijol; Jicheng Lv; Hong Zhang; Jing Jin
Journal:  J Pathol       Date:  2021-04-09       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.